34/35 - COPD Flashcards

(38 cards)

1
Q

Initial Treatment of Stable COPD

What Group & What Drug(s)?

0-1 Moderate Exacerbations
not leading to hospital admin
&
mMRC 0-1 // CAT <10
modified MRC Dyspenea Scale (QOL) // COPD Assessment Test (Symptoms)

A

Group A

ANY BRONCHODIALATOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Initial Treatment of Stable COPD

What Group & What Drug(s)?

0-1 Moderate Exacerbations
not leading to hospital admin
&
mMRC > 2 // CAT > 10
modified MRC Dyspenea Scale (QOL) // COPD Assessment Test (Symptoms)

A

Group B

LONG ACTING BRONCHODIALATOR

LABA = -TEROLs
Indaca-terol // Oloda-terol // Salme-terol // Formo-terol // Arfomo-terol

LAMA = -IUMs
+Glycopyrrolate // Tiotropium // Aclidinium // Umeclidinium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Initial Treatment of Stable COPD

What Group & What Drug(s)?

> 2 Moderate Exacerbations OR > 1 leading to Hospitilization
&
mMRC 0-1 // CAT <10
modified MRC Dyspenea Scale (QOL) // COPD Assessment Test (Symptoms

A

Group C

  • *LAMA = -IUMs**
  • *+Glycopyrrolate** // Tiotropium // Aclidinium // Umeclidinium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Initial Treatment of Stable COPD

What Group & What Drug(s)?

> 2 Moderate Exacerbations OR > 1 leading to Hospitilization
&
mMRC > 2 // CAT > 10
modified MRC Dyspenea Scale (QOL) // COPD Assessment Test (Symptoms

A

Group D

LAMA or LAMA + LABA or ICS + LABA

  • *LAMA = -IUMs**
  • *+Glycopyrrolate** // Tiotropium // Aclidinium // Umeclidinium
  • *LAMA + LABA**
  • *-IUMs** + -TEROLs
  • *ICS + LABA**
  • *-SONE** + -TEROLs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acute COPD Exacerbation

TREATMENT

A

Short Burst Corticosteroids

  • *PREDNISONE**
  • *40mg for 5-7 days**

Improves:

  • *spirometry / ABGs / Symptoms**
  • reduced RELAPSE rates @ 30 days*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Risk Factors for COPD

A

Modifiable Risks

  • *TOBACCO Smoke**
  • *Occupational Dust // Air Pollution**

NON-modifiable Risks
ASTHMA
Impaired lung growth // Infections
Genetics - a1-antitrypsin Deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Diagnosis of COPD

A

SPIROMETRY

  • *Symptoms**
  • *Cough / Sputum** (Mucus) / Dyspnea SOB

Exposure to Risk Factors
Tobacco / Occupation / Pollution
A-1 Antitrypsin Levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Assessment of COPD Exacerbation Risk

“Acute Worsening of respiratory symptoms that result in ADDITIONAL THERAPY”

Mild vs Moderate vs SEVERE

A
  • Blood Eosinophil Count** may also _predict_ *exacerbation rates
  • -> for those patients treated with LABA w/o ICS

Mild = SABD ONLY

Moderate = SABDs + AntiBiotics +/- Oral Corticosteroids

SEVERE = requires HOSPITILIZATION or visits emergency room

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Important Health Maintenance for COPD

IMMUNIZATIONS

A

Flu Vaccine –> reduces Serious Illness + Death

ALL SMOKERS SHOULD RECEIVE
–> PNEUMOCOCCAL 23 VACCINE
if 65 y/o+ –> prevnar 13 then 1 year for PCV23
SUBQ or IM
Protects against 85% of INVASIVE Pneumococcal strains

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Important Health Maintenance for COPD

PULMONARY REHABILITATION

A

EXERCISE / STRENGTH Training

Education + Adequate Nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Important Health Maintenance for COPD

SMOKING CESSATION

A

MOST EFFECTIVE intervention STOPS & REDUCES progression of COPD

Varenicline
Renal Dosing, CrCL < 30 = 0.5mg QD, MAX 0.5mg BID

Bupropion SR
150mg f3d –> 150mg BID
CI with SEIZURES – Good for Weight Gain + Depression
Hepatic = 150mg QOD // Elderly or Renal = 150mg QD

  • *NRTs**
  • not covered by insurance typically*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Albuterol - Levalbuterol

Type / ADR

A

SABA

Short Acting B2 AGONIST

not completely selective
ADRs:
HR & Contraction
HypoKalemia –> leg cramps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ipratropium

Type / ADRs

A

SAMA
Short-Acting Muscarinic ANTAGONIST

Atrovent HFA MDI
also comes in inhalation solution - 15 min onset of action

ADR:
DRY MOUTH / CV Events
Metallic taste / Blurred Vision
Urinary Retention / Tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which LAMA is considered the GOLD STANDARD?

A

LAMA = -IUMs + Glycopyrrolate

TIOTROPIUM
Spiriva Respimat

Glycopyrrolate –> Improved FEV1 > Tiotropium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LAMA
Tiotropium / Aclidinium / Umeclidinium / +Glycopyrolate

USES

Effects on Exacerbations?

A

LAMA

  • *PREVENTS_ & _TREATS**
  • *Exacerbations**

Relieves symptoms / prevents hospitalizations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

LAMA
Tiotropium / Aclidinium / Umeclidinium / +Glycopyrolate

ADR / PRECAUTIONS

A

ADR’s are the SAME as SAMA = Ipatropium
Dry mouth / blurred vision / constipation / urinary retention / glaucoma
EXCEPT:
does NOT show increase in CV EVENTS

CI:
Glaucoma / Prostatic HYPERplasia / Renal Impairment CrCl <50 mL/min

17
Q

Combination SABA/SAMA

Advantages

A

Albuterol + Ipratropium = Combivent

Combo provides greater change in spirometry than either agent alone.

Improved adherence & Cost

disadvantage
FIXED DOSE

18
Q

Which LABAs are INHALATION SOLUTIONS?

A

FORMO-TEROL** & **ARFORMO-TEROL

both 1 vial BID

Salmeterol is DPI dosed BID

19
Q

Which LABAs are
ULTRA-LONG-ACTING

“Dosed DAILY”

A
  • *INDACATEROL**
  • *1 CAP for inhalation DAILY,** ArCAPta Neohaler DPI
  • *OLODATEROL**
  • *2 Inhalers DAILY**, Striverdi Respimat

Salmeterol is DPI dosed BID

20
Q

LABA = -TEROLs
Indaca-terol // Oloda-terol // Salme-terol // Formo-terol // Arfomo-terol

USES - Effect on exacerbations?

A
  • *Prevent Exacerbations ONLY**
  • does NOT TREAT* compared to LAMA

Prevent Hospilizations / Relieve Symptoms

21
Q

LABA = -TEROLs
Indaca-terol // Oloda-terol // Salme-terol // Formo-terol // Arfomo-terol

SIDE EFFECTS

A

DPI - DRY COUGH

BLACK BOX WARNING
increased risk of ASTHMA-related deaths
never used ALONE for ASTHMA patients

Insomnia / Tremors / Palpitations

TachyCardia / QT Interval Prolongation / HypoKalemia

22
Q

When would we ADD an ICS for COPD?

A

LABA + ICS

for EXACERBATIONS:
EOS > 300

or EOS > 100 + > 2 moderate exacerbation / 1 hospitilization

Since:
COPD during EXACERBATIONS = EOSINOPHILIC INFLAMMATION

23
Q

Eosinophils & COPD

A

COPD is mainly NEUTROPHILIC Inflammation,
EXCEPT:
During EXACERBATIONS –> EOSINOPHLIC
&
pt with ASTHMA + COPD

Eosiniphils are associated with:
Risk of COPD exacerbations
Lung Function

24
Q

Which LABA/ICS combination is dosed DAILY?

A
  • *Fluticasone Furoate / Vilanterol**
  • *Breo Ellipta DPI**

1 Inhalation DAILY

25
**When would we INITIALLY use** **LABA/ICS Combination?**
**_ASTHMA_** + **COPD** or **GROUP D + _EOS**_ _**\>_** **300** _\>_ 2 Moderate Exacerbations OR _\>_ 1 leading to Hospitilization & mMRC _\>_ 2 // CAT _\>_ 10
26
**When would we use** **LABA + LAMA + ICS** Fluticasone furoate/Umeclidinium/Vilanterol Trelegy Ellipta - QD
**_STEP-UP_** for: **LABA+LAMA** when **EOS _\>_ 100** or **LABA+ICS** and **continued Exacerbations**
27
**ICS** - **ADRs** **ICS is NEVER used ALONE for COPD** **Budesonide**/ Formoterol **Fluticasone** Propionate/ Salmeterol Fluticasone propionate/ Salmeterol Fluticasone propionate/ Salmeterol Fluticasone Furoate/ Vilanterol
**_PNEUMONIA_** *not DOSE dependent, specific risk factors:* current smokers, prior pneumonia, BMI \<25 kg/m2, FEV1≥30%-\<50%, poor MRC dyspnea score) ## Footnote **_CANDIDIASIS_** **Dysphonia / Osteoporosis / Cataracts**
28
**RISK FACTORS** **for PNEUMONIA with ICS**
*NOT dose Dependent* **Prior exacerbation or Pneumonia** CURRENT **Smoker** **\> 55 y/o** **BMI \< 25** **FEV _\>_** **30-50%** **Blood Eosinophil \< 2%**
29
**Phosphodiesterase-4 Inhibitors** **Drug / Function**
**RFLUMILAST** = Daliresp ↑**cAMP** in **immunomodulatory/inflammatory cells** VV **Relax Airways** & ***supresssion*** of **Smooth muscle mitogenesis** *SUPRESSES:* **_↓NEUTROPHILS_** / **Macrophages** / **CD8 T-cells**
30
**When would we use a** **PDE4 Inhibitor = Roflumilast**
**_STEP UP_** for **LABA+LAMA** *but _EOS \< 100_* **_ADD-ON Therapy_** for **FEV1 \<50%** + **Chronic Cough/Sputum** (**bronchitis**) **1 hospitilization in past year** *NOT USED FOR EMPHYSEMA* **250 mcg PO QD f4 weeks** --\> **500 mcg PQ QD**
31
**PDE4 INHIBITOR = Roflumilast** **ADRs**
**Very common side effects --\> Need to TITRATE DOSE** 250 mcg QD for 4 weeks --\> 500 mcg PO QD **_Diarrhea**_ + _***Weight Decrease*_** + **Nausea** + **Depression** Metabolism: **_CYP3A4_**
32
**Macrolide Anti-Inflammatory** **Antibiotics** for COPD ## Footnote **Drugs / MoA**
**_Azithromycin**_ or _**Erythromycin_** ↓**Mucus+Sputum Production** * INHIBIT:* * *IL-1 / IL-6 / IL-8 / TNF-a** * *oxygen radical production of Neutrophils** * Prevent* **breakdown of neutrophils** --\> *release TOXIC substances* * IMPAIR* **migration of neutrophils**
33
**When would we use in COPD** **Macrolide Anti-Inflammatory Antibiotics​?** **& Limitations**
**_Step Up:_** **FORMER SMOKERS** (*no longer smoking)* **SEVERE COPD + Multiple Exacerbations** Adherence to Bronchodilator & Anti-inflammatory Meds Limitations: **Hearing Loss / QT interval Prolongation** **BACTERIAL RESISTANCE**
34
**COPD Monitoring**
**Quarterly = CAT** (COPD Assessment Test) **Yearly = Lung Function Test** Every Visit: Smoking Status / Symptoms / Dosing / Adherence Technique / Exacerbations / Excercise
35
**Acute COPD Exacerbations**
_Causes:_ UNKNOWN / Viral / Air Pollution / Bacterial _Rule Out:_ **Pneumonia / CHF** / Arrhythmia / Pneomothorax / PE **Symptoms: ↑****Breathlessness** / **Wheezing / Chest Tightness** ↑**Cough+Sputum** **Fever / Change in Color-Tenacity Sputum**
36
**Home Management of Acute COPD Exacerbation**
**_INTENSIFY Bronchodilator Regimen_** Nebulization -\> dose more regularly Albuterol / Ipratropium MDI --\> 4-8 puffs Duoneb --\> more doses **_ORAL CORTICOSTEROIDS_** Prednisone 40mg for 5-7 days **_Consider ANTIBIOTICS_** 3 of the following: ↑Dyspnea / ↑Sputum Volume / ↑_Sputum Purulence_
37
**When to consider ANTIBIOTICS?** for **Acute COPD Exacerbation** –Azithromycin or Clarithromycin –Doxycycline –Trimethoprim/sulfamethoxazole –Cefuroxime, cefpodoxime, cefdinir –Moxifloxacin, levofloxacin –Amoxicillin-clavulanate
**requires _Mechanical Ventilation_** or **_3 of the following symptoms_**: ↑**Dyspnea** ↑**Sputum Volume** ↑**_Sputum PURULENCE_** ***only need 2* if 1 is sputum purulence**
38
**Long Term Oxygen Therapy COPD** **MoA / Efficacy**
Main cause of death in COPD **CV disease / Lung Cancer / Respiratory Failure** MoA: Modest yearly ***decline* in pulmonary artery pressure** *REVERSES* **secondary polycythemia** ↑**cardiac function test during rest & exercise** Efficacy: ↑**Survival / QOL / Exercise tolerance ↑Judgement + Short Term Memory**